175 related articles for article (PubMed ID: 11974977)
1. Botulinum toxin (DYSPORT) in tension-type headaches.
Rollnik JD; Dengler R
Acta Neurochir Suppl; 2002; 79():123-6. PubMed ID: 11974977
[TBL] [Abstract][Full Text] [Related]
2. Treatment of tension-type headache with botulinum toxin type A: a double-blind, placebo-controlled study.
Rollnik JD; Tanneberger O; Schubert M; Schneider U; Dengler R
Headache; 2000 Apr; 40(4):300-5. PubMed ID: 10759934
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin type A and EMG: a key to the understanding of chronic tension-type headaches?
Rollnik JD; Karst M; Fink M; Dengler R
Headache; 2001; 41(10):985-9. PubMed ID: 11903527
[TBL] [Abstract][Full Text] [Related]
4. Pericranial injection of botulinum toxin type A (Dysport) for tension-type headache - a multicentre, double-blind, randomized, placebo-controlled study.
Straube A; Empl M; Ceballos-Baumann A; Tölle T; Stefenelli U; Pfaffenrath V;
Eur J Neurol; 2008 Mar; 15(3):205-13. PubMed ID: 18290842
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin A, adjunctive therapy for refractory headaches associated with pericranial muscle tension.
Wheeler AH
Headache; 1998 Jun; 38(6):468-71. PubMed ID: 9664753
[TBL] [Abstract][Full Text] [Related]
6. Effect of botulinum toxin A injections in the treatment of chronic tension-type headache: a double-blind, placebo-controlled trial.
Schmitt WJ; Slowey E; Fravi N; Weber S; Burgunder JM
Headache; 2001; 41(7):658-64. PubMed ID: 11554953
[TBL] [Abstract][Full Text] [Related]
7. Treatment of chronic tension-type headache with botulinum toxin A: a randomized, double-blind, placebo-controlled multicenter study.
Schulte-Mattler WJ; Krack P;
Pain; 2004 May; 109(1-2):110-4. PubMed ID: 15082132
[TBL] [Abstract][Full Text] [Related]
8. Treatment of tension-type headache with botox: a review of the literature.
Rozen D; Sharma J
Mt Sinai J Med; 2006 Jan; 73(1):493-8. PubMed ID: 16470328
[TBL] [Abstract][Full Text] [Related]
9. Predictors of response to botulinum toxin type A (BoNTA) in chronic daily headache.
Mathew NT; Kailasam J; Meadors L
Headache; 2008 Feb; 48(2):194-200. PubMed ID: 17868356
[TBL] [Abstract][Full Text] [Related]
10. [Botulinum toxin used against tension headaches?].
Gross H
Dtsch Med Wochenschr; 2002 Jun; 127(25-26):1361. PubMed ID: 12136791
[No Abstract] [Full Text] [Related]
11. Efficacy of Botulinum Toxin in Tension-Type Headaches: A Systematic Review of the Literature.
Freund B; Rao A
Pain Pract; 2019 Jun; 19(5):541-551. PubMed ID: 30742360
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study.
Harden RN; Cottrill J; Gagnon CM; Smitherman TA; Weinland SR; Tann B; Joseph P; Lee TS; Houle TT
Headache; 2009 May; 49(5):732-43. PubMed ID: 19178577
[TBL] [Abstract][Full Text] [Related]
13. The efficiency of botulinum toxin type A for the treatment of masseter muscle pain in patients with temporomandibular joint dysfunction and tension-type headache.
Pihut M; Ferendiuk E; Szewczyk M; Kasprzyk K; Wieckiewicz M
J Headache Pain; 2016; 17():29. PubMed ID: 27011213
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin in tension-type headache.
Relja M; Telarović S
J Neurol; 2004 Feb; 251 Suppl 1():I12-4. PubMed ID: 14991337
[TBL] [Abstract][Full Text] [Related]
15. A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after stroke.
Pittock SJ; Moore AP; Hardiman O; Ehler E; Kovac M; Bojakowski J; Al Khawaja I; Brozman M; Kanovský P; Skorometz A; Slawek J; Reichel G; Stenner A; Timerbaeva S; Stelmasiak Z; Zifko UA; Bhakta B; Coxon E
Cerebrovasc Dis; 2003; 15(4):289-300. PubMed ID: 12686794
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis.
Jackson JL; Kuriyama A; Hayashino Y
JAMA; 2012 Apr; 307(16):1736-45. PubMed ID: 22535858
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of a standardised 500 unit dose of Dysport (clostridium botulinum toxin type A haemaglutinin complex) in a heterogeneous cervical dystonia population: results of a prospective, multicentre, randomised, double-blind, placebo-controlled, parallel group study.
Wissel J; Kanovsky P; Ruzicka E; Bares M; Hortova H; Streitova H; Jech R; Roth J; Brenneis C; Müller J; Schnider P; Auff E; Richardson A; Poewe W
J Neurol; 2001 Dec; 248(12):1073-8. PubMed ID: 12013585
[TBL] [Abstract][Full Text] [Related]
18. Preventative treatment for migraine and tension-type headaches : do drugs having effects on muscle spasm and tone have a role?
Freitag FG
CNS Drugs; 2003; 17(6):373-81. PubMed ID: 12696998
[TBL] [Abstract][Full Text] [Related]
19. Use of botulinum toxin type B for migraine and tension headaches.
Fadeyi MO; Adams QM
Am J Health Syst Pharm; 2002 Oct; 59(19):1860-2. PubMed ID: 12374073
[No Abstract] [Full Text] [Related]
20. A randomized, double-blind, prospective pilot study of botulinum toxin injection for refractory, unilateral, cervicothoracic, paraspinal, myofascial pain syndrome.
Wheeler AH; Goolkasian P; Gretz SS
Spine (Phila Pa 1976); 1998 Aug; 23(15):1662-6; discussion 1667. PubMed ID: 9704373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
